Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Saturday, December 02, 2017 1:55:42 PM
bull flag
inverted head and shoulders bottom
DanDrit Biotech USA, Inc.
U.S. Office
375 Park Avenue, Suite 2607
New York, NY, 10152
United States
Phone: +1 (212) 763 0184
Danish Office
DanDrit Biotech A/S
Symbion Science Park
Fruebjergvej 3, Box 62
2100 Copenhagen
Denmark
Lab Facilities
DanDrit Biotech A/S
Symbion Science Park
Fruebjergvej 3, Box 62
2100 Copenhagen
Denmark
http://www.dandrit.com
https://mytomorrows.com/en/
DanDrit Biotech USA, Inc. is focusing on the clinical development of a dendritic cell vaccine for treatment of colorectal cancer. DanDrit Biotech A/S was founded in 2001 on the research of Professor Jesper Zeuthen at the Danish Cancer Society (Kraeftens Bekaempelse). Dendritic cells are critical components of the immune system. The ability of dendritic cells to induce a strong immune response is the basis of the vaccine therapies under development at DanDrit. Our expertise in producing dendritic cells from a patient’s blood is combined with conventional production methods to make new and advanced vaccines for cancer patients.
The proprietary technology upon which MCV is based is protected by several issued patents.
Also based on a 2011 Nobel Prize for research on dendritic cells.
normal chart
log chart
Recent RENB News
- Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics • GlobeNewswire Inc. • 04/30/2024 03:00:00 PM
- RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership • GlobeNewswire Inc. • 04/24/2024 01:00:00 PM
- Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Ca • GlobeNewswire Inc. • 04/18/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 10:00:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 10:03:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 08:20:32 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:01:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:35:47 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/22/2024 09:17:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:20:42 PM
- Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace • GlobeNewswire Inc. • 02/15/2024 02:25:00 PM
- Statement of Renovaro Inc • GlobeNewswire Inc. • 02/14/2024 03:01:30 PM
- Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace • GlobeNewswire Inc. • 02/13/2024 02:46:07 PM
- AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine • GlobeNewswire Inc. • 02/13/2024 02:31:09 PM
- Renovaro Biosciences Announces Results of Special Meeting of Shareholders • GlobeNewswire Inc. • 01/25/2024 05:45:00 PM
- Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD • GlobeNewswire Inc. • 01/16/2024 01:00:00 PM
- Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors • GlobeNewswire Inc. • 10/11/2023 01:25:00 PM
- Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors • GlobeNewswire Inc. • 10/10/2023 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 10/06/2023 08:34:03 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 10/06/2023 08:30:30 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/04/2023 08:20:26 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/04/2023 08:15:17 PM
- Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD • GlobeNewswire Inc. • 10/02/2023 04:05:40 PM
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM